Patient demographics
| . | BMT . | PBSC . | UCB . | P . |
|---|---|---|---|---|
| . | (N = 102) . | (N = 458) . | (N = 517) . | . |
| Age, y | <.01 | |||
| Median (Min-Max) | 46.3 (19.2-75.1) | 55.1 (19.0-74.8) | 50.8 (18.1-73.3) | |
| Sex, % | .03 | |||
| Male | 58 (56.9) | 289 (63.1) | 284 (54.9) | |
| Female | 44 (43.1) | 169 (36.9) | 233 (45.1) | |
| Diagnosis, % | <.01 | |||
| Acute lymphoblastic leukemia | 9 (8.8) | 49 (10.7) | 90 (17.4) | |
| AML | 21 (20.6) | 197 (43.0) | 221 (42.7) | |
| Chronic lymphocytic leukemia | 2 (2.0) | 14 (3.1) | 13 (2.5) | |
| Chronic myeloid leukemia | 21 (20.6) | 14 (3.1) | 6 (1.2) | |
| Hodgkin lymphoma | 5 (4.9) | 13 (2.8) | 27 (5.2) | |
| Myelodysplastic syndrome | 12 (11.8) | 65 (14.2) | 55 (10.6) | |
| Multiple myeloma | 6 (5.9) | 19 (4.1) | 16 (3.1) | |
| Myeloproliferative disease | 1 (1.0) | 5 (1.1) | 13 (2.5) | |
| Non-Hodgkin lymphoma | 8 (7.8) | 65 (14.2) | 67 (13.0) | |
| Other | 17 (16.7) | 17 (3.7) | 10 (1.9) | |
| Conditioning intensity, % | .21 | |||
| Myeloablative | 43 (42.2) | 153 (33.4) | 190 (36.8) | |
| Reduced intensity conditioning/non-myeloablative conditioning/other | 59 (57.8) | 305 (66.6) | 327 (63.2) | |
| Relation of donor, % | ||||
| Related | 41 (40.2) | 424 (92.6) | 0 (0) | <.01 |
| Unrelated | 61 (59.8) | 34 (7.4) | 517 (100) |
| . | BMT . | PBSC . | UCB . | P . |
|---|---|---|---|---|
| . | (N = 102) . | (N = 458) . | (N = 517) . | . |
| Age, y | <.01 | |||
| Median (Min-Max) | 46.3 (19.2-75.1) | 55.1 (19.0-74.8) | 50.8 (18.1-73.3) | |
| Sex, % | .03 | |||
| Male | 58 (56.9) | 289 (63.1) | 284 (54.9) | |
| Female | 44 (43.1) | 169 (36.9) | 233 (45.1) | |
| Diagnosis, % | <.01 | |||
| Acute lymphoblastic leukemia | 9 (8.8) | 49 (10.7) | 90 (17.4) | |
| AML | 21 (20.6) | 197 (43.0) | 221 (42.7) | |
| Chronic lymphocytic leukemia | 2 (2.0) | 14 (3.1) | 13 (2.5) | |
| Chronic myeloid leukemia | 21 (20.6) | 14 (3.1) | 6 (1.2) | |
| Hodgkin lymphoma | 5 (4.9) | 13 (2.8) | 27 (5.2) | |
| Myelodysplastic syndrome | 12 (11.8) | 65 (14.2) | 55 (10.6) | |
| Multiple myeloma | 6 (5.9) | 19 (4.1) | 16 (3.1) | |
| Myeloproliferative disease | 1 (1.0) | 5 (1.1) | 13 (2.5) | |
| Non-Hodgkin lymphoma | 8 (7.8) | 65 (14.2) | 67 (13.0) | |
| Other | 17 (16.7) | 17 (3.7) | 10 (1.9) | |
| Conditioning intensity, % | .21 | |||
| Myeloablative | 43 (42.2) | 153 (33.4) | 190 (36.8) | |
| Reduced intensity conditioning/non-myeloablative conditioning/other | 59 (57.8) | 305 (66.6) | 327 (63.2) | |
| Relation of donor, % | ||||
| Related | 41 (40.2) | 424 (92.6) | 0 (0) | <.01 |
| Unrelated | 61 (59.8) | 34 (7.4) | 517 (100) |